Figure 5 | Scientific Reports

Figure 5

From: Tissue-specific expression of the SARS-CoV-2 receptor, angiotensin-converting enzyme 2, in mouse models of chronic kidney disease

Figure 5

Effects of olmesartan administration on body weight, blood pressure, and renal function. (A) Body weight and (B) blood pressure in control, adenine, control-olmesartan, and adenine-olmesartan groups. (C) Plasma creatinine level, (D) plasma BUN level, (E) urinary albumin excretion, and (F) creatinine clearance in control, adenine, control-olmesartan, and adenine-olmesartan groups. Values are expressed as mean ± standard error of the mean (six mice per group). P values, versus control: *P < 0.05; **P < 0.01; ***P < 0.001; versus without olmesartan: †P < 0.05; ††P < 0.01; †††P < 0.001. BP, blood pressure; BUN, blood urea nitrogen.

Back to article page